Prediabetes, Exercise, and Appetite Regulation (PEAR)

October 13, 2022 updated by: Tanya Halliday, University of Utah

Alterations to Appetite Regulation Indices in Adults With Prediabetes Following Short-Term Aerobic vs. Resistance Exercise Training

The purpose of the study is to learn about how type of exercise influences measures of appetite regulation.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

The primary objective of this study is to understand the relationship between exercise modality and appetite regulation in a population with pre-diabetes. The study includes a screening visit to ensure eligibility of participants, baseline assessments, a resistance exercise intervention, and post intervention measurements. The variables of interest include, but are not limited to, hormonal responses to exercise training pertaining to appetite, food cravings, appetite ratings. activity levels, body composition, and ten repetition-max strength. The aim of this study is to better understand the mechanisms involved in the correlation or causation of any improvements in fitness and appetite regulation in a cohort with pre-diabetes.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84112
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-50 years of age
  • BMI between 27-40 kg/m²
  • Hemoglobin A1c level between 5.7% and 6.4%
  • Physical Activity (less than 150 min/week moderate-intensity Physical Activity, no more than 1 session/week of resistance exercise)

Exclusion Criteria:

  • Unstable Cardiovascular Disease
  • Uncontrolled hypertension
  • Severe hypertriglyceridemia
  • History of or active liver disease
  • Uncontrolled thyroid disease
  • Active cancer diagnosis
  • Smoking
  • Engaged in exercise or diet program
  • History of bariatric surgery
  • GI malabsorptive disorders
  • Significant diet intolerances
  • History of major psychiatric disorder
  • presence of alcohol or substance abuse;
  • medications affecting weight,
  • EI or EE in past 6 months;
  • women currently pregnant, lactating, less than 6 months post-partum, or postmenopausal.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Resistance Exercise
Resistance exercise will be training all major muscle groups 2x/week (2 days upper body, 2 days lower body) at 40-50% 1 repetition max (RM; estimated from 10 RM baseline testing) for 3 sets of 10-12 reps. This equals 4x/week for the 3 week intervention period.
Increasing strength and fitness and thereby influencing hormones and perceptions involved in appetite regulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Appetite Rating
Time Frame: Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
Hunger/Satiety before/after consumption of a meal
Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
Changes in Hormonal Response to Feeding
Time Frame: Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
Assessment of Ghrelin levels analyzed in blood samples before/after feeding.
Baseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Body Composition
Time Frame: Baseline and Post-intervention(Week 4)
Measured via BodPod
Baseline and Post-intervention(Week 4)
Changes in Maximal Strength
Time Frame: Baseline and Post-intervention(Week 4)
Measurement via 10 repetition-max testing.
Baseline and Post-intervention(Week 4)
Changes in Physical Activity Levels
Time Frame: Baseline and Post-intervention(Week 4)
Measured via ActivPal Monitor
Baseline and Post-intervention(Week 4)
Changes in Food-Related Behaviors
Time Frame: Baseline and Post-intervention(Week 4)
Evaluated via the Food Craving Inventory
Baseline and Post-intervention(Week 4)
Changes in Food-Related Behaviors
Time Frame: Baseline and Post-intervention(Week 4)
Evaluated via Three-Factor Eating Questionnaire
Baseline and Post-intervention(Week 4)
Changes in Food-Related Behaviors
Time Frame: Baseline and Post-intervention(Week 4)
Evaluated via the Weight Efficacy Lifestyle Questionnaire
Baseline and Post-intervention(Week 4)
Change in Ad libitum Energy Intake - In lab
Time Frame: Baseline and Post-intervention(Week 4)
In lab ad libitum buffet lunch (via weigh and measure methodology)
Baseline and Post-intervention(Week 4)
Changes in Ad libitum Energy Intake - Free Living
Time Frame: Baseline and Post-intervention(Week 4)
3 days of free-living ad libitum energy intake (via self-report)
Baseline and Post-intervention(Week 4)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tanya M Halliday, PhD, RD, University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2019

Primary Completion (Actual)

September 3, 2021

Study Completion (Actual)

September 28, 2022

Study Registration Dates

First Submitted

April 19, 2021

First Submitted That Met QC Criteria

June 1, 2021

First Posted (Actual)

June 2, 2021

Study Record Updates

Last Update Posted (Actual)

October 17, 2022

Last Update Submitted That Met QC Criteria

October 13, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PreDiabetes

Clinical Trials on Resistance Exercise

3
Subscribe